Zynex, Inc. Aktie News

Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard talked with Proactive about his decision to step down from his position after nearly three decades leading the medical device company. He described the challenges of starting a company with no funding, navigating public listings, and expanding operations to help over a million patients manage pain.

ENGLEWOOD, Colo. , July 2, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company received an update from Tricare that the temporary payment suspension will continue.

Zynex Inc (NASDAQ:ZYXI) has announced the appointment of Steve Dyson as chief executive officer, marking a new chapter for the medical technology company founded in 1996 by its outgoing CEO Thomas Sandgaard.  Sandgaard will continue to serve as chairman of the board and will also lead the company's Technology Committee.

ENGLEWOOD, Colo. , June 30, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Steven Dyson as Chief Executive Officer.

Zynex Inc (NASDAQ:ZYXI) announced that it has been issued a UK patent for its multiparameter, non-invasive sepsis monitor. The company highlighted that its patented technology is designed to continuously track multiple physiological signals with the goal of providing early alerts on patient trends and potential sepsis development.

ENGLEWOOD, Colo. , June 25, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been awarded UK patent 2617515 for a multiparameter, noninvasive sepsis monitor.

Zynex Inc (NASDAQ:ZYXI) CEO Thomas Sandgaard talked with Proactive about the company's recent FDA submission for a new non-invasive pulse oximeter. The device, according to Sandgaard, offers improved accuracy in measuring oxygen levels, particularly for individuals with darker skin tones or conditions like carbon monoxide poisoning.

Investors can contact the law firm at no cost to learn more about recovering their losses